|
(Mark One)
|
|||
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
for the quarterly period ended
|
||
|
or
|
|||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
for the transition period from ____ to ____
|
|
Commission File Number
|
|
|
|
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
(State of incorporation)
|
(I.R.S. Employer Identification Number)
|
|
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Registrant’s telephone number, including area code: (
|
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
|
Smaller reporting company
|
|
Emerging growth company
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||
|
|
|
|
|
|
|
Page
|
|
PART I.
|
FINANCIAL INFORMATION
|
3
|
|
Item 1.
|
Financial Statements (unaudited)
|
|
|
|
3
|
|
|
|
4
|
|
|
|
5
|
|
|
|
6
|
|
|
|
7
|
|
|
|
8
|
|
|
Item 2.
|
21
|
|
|
Item 3.
|
32 |
|
|
Item 4.
|
33 |
|
|
PART II.
|
33 |
|
|
Item 1.
|
33 |
|
|
Item 1A.
|
33 |
|
|
Item 2.
|
34 |
|
|
Item 3
|
34 |
|
|
Item 4
|
34 |
|
|
Item 5.
|
34 |
|
|
Item 6.
|
35 |
|
March 31, 2022
|
December 31, 2021
|
|||||||
|
(unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Contract receivables, net
|
|
|
||||||
|
Prepaid expenses and other current assets
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
Equipment, software and leasehold improvements, net
|
|
|
||||||
|
Software development costs, net
|
|
|
||||||
|
Goodwill
|
|
|
||||||
|
Intangible assets, net
|
|
|
||||||
| Restricted cash - long term | ||||||||
|
Operating lease right-of-use assets, net
|
|
|
||||||
|
Other assets
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Line of credit
|
$
|
|
$
|
|
||||
|
Current portion of long-term note
|
|
|
||||||
|
Accounts payable
|
|
|
||||||
|
Accrued expenses
|
|
|
||||||
|
Accrued compensation
|
|
|
||||||
|
Billings in excess of revenue earned
|
|
|
||||||
|
Accrued warranty
|
|
|
||||||
|
Income taxes payable
|
|
|
||||||
|
Derivative liabilities
|
||||||||
|
Other current liabilities
|
|
|
||||||
|
Total current liabilities
|
|
|
||||||
|
Long-term note, less current portion
|
|
|
||||||
|
Operating lease liabilities noncurrent
|
|
|
||||||
|
Other noncurrent liabilities
|
|
|
||||||
|
Total liabilities
|
|
|
||||||
|
Commitments and contingencies (Note 16)
|
||||||||
|
Stockholders’ equity:
|
||||||||
|
Preferred stock $
|
|
|
||||||
|
Common stock $
|
|
|
||||||
|
Additional paid-in capital
|
|
|
||||||
|
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||
|
Accumulated other comprehensive income (loss)
|
|
(
|
)
|
|||||
|
Treasury stock at cost,
|
(
|
)
|
(
|
)
|
||||
|
Total stockholders’ equity
|
|
|
||||||
|
Total liabilities and stockholders’ equity
|
$
|
|
$
|
|
||||
|
Three months ended
|
||||||||
|
March 31, 2022
|
March 31, 2021
|
|||||||
|
Revenue
|
$ | $ | ||||||
|
Cost of revenue
|
||||||||
|
Gross profit
|
||||||||
|
Operating expenses:
|
||||||||
|
Selling, general and administrative
|
||||||||
|
Research and development
|
||||||||
|
Restructuring charges
|
||||||||
|
Depreciation
|
||||||||
|
Amortization of intangible assets
|
||||||||
|
Total operating expenses
|
||||||||
|
Operating loss
|
( |
) | ( |
) | ||||
|
Interest expense, net
|
( |
) | ( |
) | ||||
|
Change in fair value of derivative instruments, net
|
( |
) | ||||||
|
Other income, net
|
||||||||
|
Loss before income taxes
|
( |
) | ( |
) | ||||
|
Provision for (benefit from) income taxes
|
( |
) | ||||||
|
Net loss
|
$ | ( |
) | $ | ( |
) | ||
|
Net loss per common share - basic and diluted
|
$ | ( |
) | $ | ( |
) | ||
|
Weighted average shares outstanding used to compute net loss per share - basic and diluted
|
||||||||
|
Three months ended
|
||||||||
|
March 31, 2022
|
March 31, 2021
|
|||||||
|
Net loss
|
$ | ( |
) | $ | ( |
) | ||
|
Cumulative translation adjustment
|
||||||||
|
Comprehensive loss
|
$ | ( |
) | $ | ( |
) | ||
|
Common Stock
|
Treasury Stock
|
|||||||||||||||||||||||||||||||
|
Three Months Ended
|
Shares
|
Amount
|
Additional
Paid-in
Capital
|
Accumulated
Deficit
|
Accumulated
Other
Comprehensive
Loss
|
Shares |
Amount
|
Total
|
||||||||||||||||||||||||
|
Balance, January 1, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||||
|
Stock-based compensation expense
|
-
|
|
|
|
|
-
|
|
|
||||||||||||||||||||||||
|
Common stock issued for RSUs vested
|
|
|
(
|
)
|
|
|
-
|
|
|
|||||||||||||||||||||||
|
Shares withheld to pay taxes
|
-
|
|
(
|
)
|
|
|
-
|
|
(
|
)
|
||||||||||||||||||||||
|
Foreign currency translation adjustment
|
-
|
|
|
|
|
-
|
|
|
||||||||||||||||||||||||
|
Net loss
|
-
|
|
|
(
|
)
|
|
-
|
|
(
|
)
|
||||||||||||||||||||||
|
Balance, March 31, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|||||||||||||||
|
Balance, January 1, 2021
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||||
|
Stock-based compensation expense
|
-
|
|
|
|
|
-
|
|
|
||||||||||||||||||||||||
|
Common stock issued for RSUs vested
|
|
|
|
|
|
-
|
|
|
||||||||||||||||||||||||
|
Shares withheld to pay taxes
|
-
|
|
(
|
)
|
|
|
-
|
|
(
|
)
|
||||||||||||||||||||||
|
Foreign currency translation adjustment
|
-
|
|
|
|
|
-
|
|
|
||||||||||||||||||||||||
|
Net loss
|
-
|
|
|
(
|
)
|
|
-
|
|
(
|
)
|
||||||||||||||||||||||
|
Balance, March 31, 2021
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|
Three months ended
|
||||||||
|
March 31, 2022
|
March 31, 2021
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
||||||||
|
Depreciation
|
|
|
||||||
|
Amortization of intangible assets
|
|
|
||||||
|
Amortization of capitalized software development costs
|
|
|
||||||
|
Amortization of deferred financing costs
|
|
|
||||||
|
Amortization of debt discount
|
||||||||
|
Stock-based compensation expense
|
|
|
||||||
|
Bad debt expense
|
|
|
||||||
|
Change in fair value of derivative instruments, net
|
|
|
||||||
|
Deferred income taxes
|
||||||||
|
Changes in assets and liabilities:
|
||||||||
|
Contract receivables, net
|
|
(
|
)
|
|||||
|
Prepaid expenses and other assets
|
|
(
|
)
|
|||||
|
Accounts payable, accrued compensation and accrued expenses
|
|
|
||||||
|
Billings in excess of revenue earned
|
|
(
|
)
|
|||||
|
Accrued warranty
|
|
(
|
)
|
|||||
|
Other liabilities
|
(
|
|
||||||
|
Net cash provided by (used in) operating activities
|
|
(
|
)
|
|||||
|
Cash flows from investing activities:
|
||||||||
|
Capital expenditures
|
(
|
)
|
(
|
)
|
||||
|
Capitalized software development costs
|
(
|
)
|
(
|
)
|
||||
|
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
||||
|
Cash flows from financing activities:
|
||||||||
|
Repayment of line of credit
|
(
|
)
|
(
|
)
|
||||
|
Repayment of insurance premium
|
(
|
)
|
(
|
)
|
||||
|
Proceeds from issuance of long-term note, net of debt issuance cost and original issue discount
|
|
|
||||||
|
Shares withheld to pay taxes
|
(
|
)
|
(
|
)
|
||||
|
Net cash provided by (used in) financing activities
|
|
(
|
)
|
|||||
|
Effect of exchange rate changes on cash
|
(
|
)
|
(
|
)
|
||||
|
Net increase (decrease) in cash, cash equivalents and restricted cash
|
|
(
|
)
|
|||||
|
Cash, cash equivalents and restricted cash at beginning of the period
|
|
|
||||||
|
Cash, cash equivalents and restricted cash at the end of the period
|
$
|
|
$
|
|
||||
| Cash and cash equivalents |
$ | $ | ||||||
| Restricted cash included in other long-term assets |
||||||||
| Total cash, cash equivalents, and restricted cash |
$ | $ |
| Supplemental cash flow disclosures: |
||||||||
|
Non-cash financing activities
|
||||||||
|
Discount on issuance of Convertible Note
|
$ | $ | ||||||
|
(in thousands, except for share amounts)
|
Three months ended | |||||||
|
|
March 31,
|
|||||||
|
2022
|
2021
|
|||||||
|
Numerator:
|
||||||||
|
Net loss attributed to common stockholders
|
$ | ( |
) | $ | ( |
) | ||
|
Denominator:
|
||||||||
|
Weighted-average shares outstanding for basic
earnings per share
|
||||||||
|
Effect of dilutive securities:
|
||||||||
|
RSUs
|
||||||||
|
Adjusted weighted-average shares outstanding and assumed
conversions for diluted earnings per share
|
||||||||
|
Shares related to dilutive securities excluded because inclusion
would be anti-dilutive
|
||||||||
|
(in thousands)
|
March 31, 2022
|
December 31, 2021
|
||||||
|
Billed receivables
|
$
|
|
$
|
|
||||
|
Unbilled receivables
|
|
|
||||||
|
Allowance for doubtful accounts
|
(
|
)
|
(
|
)
|
||||
|
Total contract receivables, net
|
$
|
|
$
|
|
||||
|
(in thousands)
|
As of March 31, 2022
|
|||||||||||
|
Gross Carrying Amount
|
Accumulated Amortization
|
Net
|
||||||||||
|
Amortized intangible assets:
|
||||||||||||
|
Customer relationships
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
|
Trade names
|
|
(
|
)
|
|
||||||||
|
Developed technology
|
|
(
|
)
|
|
||||||||
|
Non-contractual customer relationships
|
|
(
|
)
|
|
||||||||
|
Noncompete agreement
|
|
(
|
)
|
|
||||||||
|
Alliance agreement
|
|
(
|
)
|
|
||||||||
|
Others
|
|
(
|
)
|
|
||||||||
|
Total
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
|
(in thousands)
|
As of December 31, 2021
|
|||||||||||
|
Gross Carrying
Amount
|
Accumulated
Amortization
|
Net
|
||||||||||
|
Amortized intangible assets:
|
||||||||||||
|
Customer relationships
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
|
Trade names
|
|
(
|
)
|
|
||||||||
|
Developed technology
|
|
(
|
)
|
|
||||||||
|
Non-contractual customer relationships
|
|
(
|
)
|
|
||||||||
|
Noncompete agreement
|
|
(
|
)
|
|
||||||||
|
Alliance agreement
|
|
(
|
)
|
|
||||||||
|
Others
|
|
(
|
)
|
|
||||||||
|
Total
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
|
(in thousands)
|
||||
|
Years ended December 31:
|
||||
|
2022 remainder
|
$
|
|
||
|
2023
|
|
|||
|
2024
|
|
|||
|
2025
|
|
|||
|
2026
|
|
|||
|
Thereafter
|
|
|||
|
Total
|
$
|
|
||
|
(in thousands)
|
||||||||
|
March 31, 2022
|
December 31, 2021
|
|||||||
|
Computer and equipment
|
$
|
|
$
|
|
||||
|
Software
|
|
|
||||||
|
Leasehold improvements
|
|
|
||||||
|
Furniture and fixtures
|
|
|
||||||
|
|
|
|||||||
|
Accumulated depreciation
|
(
|
)
|
(
|
)
|
||||
|
Equipment, software and leasehold improvements, net
|
$
|
|
$
|
|
||||
|
Exercise Price
|
$ | |||
|
Common Stock Price
|
$ | |||
|
Risk Free Rate
|
||||
|
Volatility
|
||||
|
Term (in years)
|
||||
|
(in thousands)
|
Quoted Prices
in Active Markets
for Identical Assets
(Level 1)
|
Significant
Other Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
||||||||||||
|
Money market funds
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Total assets
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
| Derivative liability | $ | $ | $ | $ | ||||||||||||
| Warrant liability |
||||||||||||||||
|
Cash settled performance-vesting restricted stock units
|
||||||||||||||||
| Total liabilities | $ | $ | $ | $ | ||||||||||||
|
(in thousands)
|
Quoted Prices
in Active Markets
for Identical Assets
(Level 1)
|
Significant
Other Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
||||||||||||
|
Money market funds
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Total assets
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
(in thousands)
|
Embedded
Redemption Features
|
Warrant | Level 3 Total |
|||||||||
|
Balance at December 31, 2021
|
$
|
|
$ | $ | ||||||||
|
Derivative liabilities at issuance date
|
|
|||||||||||
|
Warrant liabilities at issuance date
|
||||||||||||
|
Change in fair value included in gain on derivative instruments, net
|
(
|
)
|
||||||||||
|
Balance at March 31, 2022
|
$
|
|
$ | $ | ||||||||
|
Amount
|
||||
|
Convertible Note issued
|
$
|
|
||
|
Debt discount
|
(
|
)
|
||
|
Issuance cost:
|
||||
|
Commitment fee
|
(
|
)
|
||
|
Balance of investor’s counsel fees
|
(
|
)
|
||
|
Net proceeds of Convertible Note
|
$
|
|
||
| Fair value of Warrant Liabilities on issuance |
( |
) | ||
| Fair value of Conversion Feature on issuance |
( |
) | ||
|
Allocated OID costs to Convertible Note
|
( |
) | ||
| Interest expense accrued on Convertible Note as of March 31, 2022 |
||||
| Balance of Convertible Note as of March 31, 2022 |
$ | |||
|
(in thousands)
|
||||
|
Balance at January 1, 2022
|
$
|
|
||
|
Current period recovery
|
|
|||
|
Current period claims
|
(
|
)
|
||
|
Currency adjustment
|
(
|
)
|
||
|
Balance at March 31, 2022
|
$
|
|
||
| |
Three months ended
|
|||||||
| (in thousands) |
March 31, 2022
|
March 31, 2021
|
||||||
|
Performance Improvement Solutions
|
||||||||
|
System Design and Build
|
$
|
$
|
||||||
|
Point in time
|
||||||||
|
Over time
|
||||||||
|
Software and Support
|
||||||||
|
Point in time
|
||||||||
|
Over time
|
||||||||
|
Training and Consulting Services
|
||||||||
|
Point in time
|
||||||||
|
Over time
|
||||||||
|
Workforce Solutions
|
||||||||
|
Training and Consulting Services
|
||||||||
|
Point in time
|
||||||||
|
Over time
|
||||||||
|
Total revenue
|
$
|
$
|
||||||
| (in thousands) |
Three months ended
|
|||||||
|
March 31, 2022
|
March 31, 2021
|
|||||||
|
Revenue recognized in the period from amounts
included in Billings in Excess of Revenue Earned at the beginning of the period
|
$
|
|
$
|
|
||||
|
(in thousands)
|
Three months ended
|
|||||||
|
March 31, 2022
|
March 31, 2021
|
|||||||
|
Income (loss) before income taxes
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Provision for income taxes
|
|
(
|
)
|
|||||
|
Effective tax rate
|
(
|
)%
|
|
%
|
||||
|
As of
|
||||||||||
|
Operating Leases
|
Classification
|
March 31, 2022
|
December 31, 2021
|
|||||||
|
Leased Assets
|
||||||||||
|
Operating lease - right of use assets
|
|
$
|
|
$
|
|
|||||
|
Lease Liabilities
|
||||||||||
|
Operating lease liabilities - Current
|
|
|
|
|||||||
|
Operating lease liabilities
|
|
|
|
|||||||
| |
$ |
|
$
|
|
||||||
|
Three months ended
|
||||||||||
|
Lease Cost
|
Classification
|
March 31,
2022
|
March 31,
2021
|
|||||||
|
Operating lease cost (1)
|
Selling, general and administrative expenses
|
$
|
|
$
|
|
|||||
|
Short-term leases costs (2)
|
Selling, general and administrative expenses
|
|
|
|||||||
|
Sublease income (3)
|
Selling, general and administrative expenses
|
(
|
)
|
(
|
)
|
|||||
|
Net lease cost
|
|
|
|
$
|
|
|||||
|
(in thousands)
|
Gross Future
Minimum Lease
Payments
|
|||
|
2022 remainder
|
$
|
|
||
|
2023
|
|
|||
|
2024
|
|
|||
|
2025
|
|
|||
|
2026
|
|
|||
|
Total lease payments
|
$
|
|
||
|
Less: Interest
|
|
|||
|
Present value of lease payments
|
$
|
|
||
|
Lease Term and Discount Rate
|
March 31, 2022
|
December 31, 2021
|
||||||
|
Weighted-average remaining lease term (years)
|
||||||||
|
Operating leases
|
|
|
||||||
|
Weighted-average discount rate
|
||||||||
|
Operating leases
|
||||||||
|
(in thousands)
|
Three months ended
|
|||||||
|
Cash paid for amounts included in
measurement of liabilities
|
March 31, 2022
|
March 31, 2021
|
||||||
|
Operating cash flows used in operating leases
|
$
|
|
$
|
|
||||
|
(in thousands)
|
Three months ended
|
|||||||
|
March 31, 2022
|
March 31, 2021
|
|||||||
|
Revenue:
|
||||||||
|
Performance Improvement Solutions
|
$
|
|
$
|
|
||||
|
Workforce Solutions
|
|
|
||||||
|
Total revenue
|
$
|
|
$
|
|
||||
|
Operating loss
|
||||||||
|
Performance Improvement Solutions
|
$
|
|
$
|
(
|
)
|
|||
|
Workforce Solutions
|
(
|
)
|
(
|
)
|
||||
|
Loss on impairment
|
|
|
||||||
|
Operating loss
|
(
|
)
|
(
|
)
|
||||
|
Interest expense, net
|
(
|
)
|
(
|
)
|
||||
| Change in fair value of derivative instruments, net |
(
|
)
|
|
|||||
|
Other income, net
|
|
|
||||||
|
Loss before income taxes
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
| • |
optimization of existing generation assets
|
| • |
design support and deployment of advanced reactor designs
|
| • |
integration with renewable power sources
|
| • |
Design engineering for plant mechanical, electrical, I&C, civil and structural, fire protection and cyber systems
|
| • |
Engineering programs addressing ASME codes, balance of plant programs other regulatory programs and economic driven programs such as plant thermal performance
|
| • |
Simulation engineering for nuclear, thermal and process plant training and virtual commissioning
|
|
Three months ended
|
||||||||||||||||
|
(in thousands)
|
March 31, 2022
|
March 31, 2021
|
||||||||||||||
| $ |
%
|
$ |
%
|
|||||||||||||
|
Revenue
|
$
|
12,275
|
100.0
|
%
|
$
|
13,104
|
100.0
|
%
|
||||||||
|
Cost of revenue
|
9,848
|
80.2
|
%
|
10,176
|
77.7
|
%
|
||||||||||
|
Gross profit
|
2,427
|
19.8
|
%
|
2,928
|
22.3
|
%
|
||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Selling, general and administrative
|
4,507
|
36.5
|
%
|
3,734
|
28.5
|
%
|
||||||||||
|
Research and development
|
142
|
1.2
|
%
|
157
|
1.2
|
%
|
||||||||||
|
Restructuring charges
|
-
|
0.0
|
%
|
808
|
6.2
|
%
|
||||||||||
|
Loss on impairment
|
-
|
0.0
|
%
|
-
|
0.0
|
%
|
||||||||||
|
Depreciation
|
72
|
0.6
|
%
|
76
|
0.6
|
%
|
||||||||||
|
Amortization of intangible assets
|
260
|
2.1
|
%
|
340
|
2.6
|
%
|
||||||||||
|
Total operating expenses
|
4,981
|
40.6
|
%
|
5,115
|
39.0
|
%
|
||||||||||
|
Operating loss
|
2,554
|
|
(20.9
|
)%
|
(2,187
|
)
|
(16.8
|
)%
|
||||||||
|
Interest expense, net
|
(148
|
)
|
(1.2
|
)%
|
(54
|
)
|
(0.4
|
)%
|
||||||||
|
Change in fair value of derivative instruments, net
|
(581
|
)
|
(4.9
|
)%
|
-
|
0.0
|
%
|
|||||||||
|
Other income, net
|
16 |
0.1
|
%
|
1
|
0.0
|
%
|
||||||||||
|
Loss before income taxes
|
(3,267
|
)
|
(26.6
|
)%
|
(2,240
|
)
|
(17.1
|
)%
|
||||||||
|
Provision for (benefit from) income taxes
|
167
|
1.4
|
%
|
(35
|
)
|
(0.3
|
)%
|
|||||||||
|
Net loss
|
$
|
(3,434
|
)
|
(28.0
|
)%
|
$
|
(2,205
|
)
|
(16.8
|
)%
|
||||||
|
Three months ended
|
||||||||||||||||
|
(in thousands)
|
March 31, 2022
|
March 31, 2021
|
Change
|
|||||||||||||
|
Revenue:
|
$ |
%
|
||||||||||||||
|
Performance Improvement Solutions
|
$
|
6,397
|
$
|
7,081
|
(684
|
)
|
(10
|
)%
|
||||||||
|
Workforce Solutions
|
5,878
|
6,023
|
(145
|
)
|
(2
|
)%
|
||||||||||
|
Total revenue
|
$
|
12,275
|
$
|
13,104
|
(829
|
)
|
(6
|
)%
|
||||||||
|
Three months ended
|
||||||||||||||||
|
March 31, 2022
|
March 31, 2021
|
|||||||||||||||
|
(in thousands)
|
$
|
%
|
$
|
%
|
||||||||||||
|
Gross profit:
|
||||||||||||||||
|
Performance Improvement Solutions
|
$
|
1,815
|
28.4
|
%
|
$
|
2,192
|
31.0
|
%
|
||||||||
|
Workforce Solutions
|
612
|
10.4
|
%
|
736
|
12.2
|
%
|
||||||||||
|
Total gross profit
|
$
|
2,427
|
19.8
|
%
|
$
|
2,928
|
22.3
|
%
|
||||||||
|
Three months ended
|
||||||||||||||||
|
(in thousands)
|
March 31, 2022
|
%
|
March 31, 2021
|
%
|
||||||||||||
|
Selling, general and administrative expenses:
|
||||||||||||||||
|
Corporate charges
|
$
|
3,482
|
77.3
|
%
|
$
|
2,758
|
73.9
|
%
|
||||||||
|
Business development
|
839
|
18.6
|
%
|
767
|
20.5
|
%
|
||||||||||
|
Facility operation & maintenance (O&M)
|
177
|
3.9
|
%
|
200
|
5.4
|
%
|
||||||||||
|
Bad debt expense
|
-
|
0.0
|
%
|
4
|
0.1
|
%
|
||||||||||
|
Other
|
9
|
0.2
|
%
|
5
|
0.1
|
%
|
||||||||||
|
Total
|
$
|
4,507
|
100.0
|
%
|
$
|
3,734
|
100.0
|
%
|
||||||||
|
Three months ended
|
||||||||
|
March 31, 2022
|
March 31, 2021
|
|||||||
|
Net loss
|
$
|
(3,434
|
)
|
$
|
(2,205
|
)
|
||
|
Interest expense, net
|
148
|
54
|
||||||
|
Provision for income taxes
|
167
|
(35
|
)
|
|||||
|
Depreciation and amortization
|
415
|
513
|
||||||
|
EBITDA
|
(2,704
|
)
|
(1,673
|
)
|
||||
|
Restructuring charges
|
-
|
808
|
||||||
|
Stock-based compensation expense
|
408
|
38
|
||||||
|
Change in fair value of derivative instruments, net
|
581 |
-
|
||||||
|
Adjusted EBITDA
|
$
|
(1,715
|
)
|
$
|
(827
|
)
|
||
|
(in thousands)
|
Three months ended
|
|||||||
|
March 31, 2022
|
March 31, 2021
|
|||||||
|
Net loss
|
$
|
(3,434
|
)
|
$
|
(2,205
|
)
|
||
|
Restructuring charges
|
-
|
808
|
||||||
|
Stock-based compensation expense
|
408
|
38
|
||||||
|
Change in fair value of derivative instruments, net
|
581 |
-
|
||||||
|
Amortization of intangible assets related to acquisitions
|
260
|
340
|
||||||
|
Adjusted net loss
|
$
|
(2,185
|
)
|
$
|
(1,019
|
)
|
||
|
Adjusted loss per common share – Diluted
|
$
|
(0.10
|
)
|
$
|
(0.05
|
)
|
||
|
Weighted average shares outstanding used to compute adjusted net loss per share - basic and diluted(1)
|
20,980,046
|
20,628,669
|
||||||
| Item 3. |
Quantitative and Qualitative Disclosure about Market Risk
|
| Item 4. |
Controls and Procedures
|
| Item 1. |
Legal Proceedings
|
| Item 1A. |
Risk Factors
|
| Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds
|
| Item 3. |
Defaults Upon Senior Securities
|
| Item 4. |
Mine Safety Disclosures
|
| Item 5. |
Other Information
|
| Item 6. |
Exhibits
|
|
Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes- Oxley Act of 2002, filed herewith.
|
||
|
Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.
|
||
|
Certification of the Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, filed herewith.
|
||
|
Eighth Amendment
|
||
|
101.INS*
|
XBRL Instance Document
|
|
|
101.SCH*
|
XBRL Taxonomy Extension Schema
|
|
|
101.CAL*
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
|
101.DEF*
|
XBRL Taxonomy Extension Definition Linkbase
|
|
|
101.LAB*
|
XBRL Taxonomy Extension Label Linkbase
|
|
|
101.PRE*
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
Date: May 16, 2022
|
|
|
GSE SYSTEMS, INC.
|
|
|
/S/ KYLE J. LOUDERMILK
|
|
|
Kyle J. Loudermilk
|
|
|
Chief Executive Officer
|
|
|
(Principal Executive Officer)
|
|
|
/S/ EMMETT A. PEPE
|
|
|
Emmett A. Pepe
|
|
|
Chief Financial Officer
|
|
|
(Principal Financial and Accounting Officer)
|